EHTH · Quarterly Report (Form 10-Q) · Filed August 5, 2026

Ehealth Inc — 10-Q exhibit

exhibit104amendmenttosever.htm

Document

EHEALTH, INC.

AMENDMENT TO SEVERANCE AGREEMENT

RECITALS

WHEREAS, eHealth, Inc. (the “Company”) and John J. Dolan (“Executive”) previously entered into a Severance Agreement, effective as of August 31, 2024 (the “Agreement”); and

WHEREAS, the Company and Executive wish to amend the Agreement on the terms set forth herein.

NOW, THEREFORE, effective as of the date hereof, the Agreement is amended as follows pursuant to this Amendment to Severance Agreement (the “Amendment”):

AGREEMENT

1.The last sentence in Section 2(b)(ii) of the Agreement titled “Equity Award Vesting” is hereby deleted in its entirety and replaced with the following sentence for purposes of correcting a drafting error in the original Agreement:

"For the avoidance of doubt, all performance-based equity awards for which performance goals have been achieved but which remain subject to time-based vesting shall be considered time-based awards under the terms of this Agreement but shall otherwise be governed by the applicable incentive plan and the award agreements pursuant to which the performance-based equity awards were granted.”

2. Except as amended hereby, the terms of the Agreement remain in full force and effect.

This Amendment shall be effective as of the last date on which it is executed by both parties below.


									EHEALTH, INC.
									By: /s/ Derrick A. Duke
									Name: Derrick A. Duke
									Title: Chief Executive Officer
									Date: August 4, 2026


									EXECUTIVE
									/s/ John J. Dolan
									Name: John J. Dolan
									Date: August 4, 2026

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer